• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Seven-Day Recall Tests Reveal Accelerated Long-Term Memory Forgetting in Multiple Sclerosis

by
November 18, 2026
in Health
Reading Time: 6 mins read
0
Seven-Day Recall Tests Reveal Accelerated Long-Term Memory Forgetting in Multiple Sclerosis

Seven-Day Recall Tests Reveal Accelerated Long-Term Memory Forgetting in Multiple Sclerosis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A clinical study evaluating memory retention in multiple sclerosis has revealed that patients experience accelerated long-term forgetting over seven days despite demonstrating intact initial learning and normal retention during standard short-delay testing. Conducted by researchers at the Evangelical Hospital and Carl von Ossietzky University in Oldenburg, Germany, the investigation compared 62 patients diagnosed with multiple sclerosis against 65 healthy control participants matched closely for age, sex, and years of formal education. While routine clinical assessments frequently fail to capture subtle cognitive complaints voiced by individuals living with this chronic autoimmune condition, tracking verbal recall across a full week revealed a pronounced deficit in extended storage. When measured using standardized word-list and story-learning tests, participants with multiple sclerosis demonstrated significantly reduced retention quotients compared to healthy peers, providing objective verification for memory symptoms that standard thirty-minute delayed evaluations typically overlook.

Multiple sclerosis is a chronic, autoimmune-mediated neurological condition representing the primary cause of non-traumatic disability among young adults, frequently manifesting during active early adulthood and exerting substantial lifelong consequences on quality of life. Although cognitive deficits, particularly memory deterioration, affect many patients, these impairments remain difficult to detect during routine outpatient examinations where evaluations rarely extend beyond short delays. In clinical settings, individuals with multiple sclerosis frequently report subjective memory impairment, yet their self-reported difficulties often lack objective corroboration on conventional neuropsychological test batteries. Researchers have consequently investigated accelerated long-term forgetting, an atypical cognitive pattern characterized by an increased rate of memory loss across extended intervals despite preserved initial encoding and intact immediate recall. While long-term forgetting has previously been documented in temporal lobe epilepsy, traumatic brain injury, transient ischemic attack, minor stroke, and limbic encephalitis, its presence in broader clinical cohorts of multiple sclerosis had previously been explored only in a single pilot study of mildly impaired patients.

To establish whether accelerated forgetting represents a widespread phenomenon across a diverse clinical population, the investigators established strict enrollment criteria at the university outpatient clinic in Oldenburg. Eligible participants were native German speakers aged eighteen years or older with clinically confirmed relapsing-remitting, secondary progressive, or primary progressive multiple sclerosis diagnosed according to the revised 2017 McDonald criteria. To prevent external neurochemical factors from confounding memory performance, the protocol excluded anyone who had received central nervous system-active medication, including corticosteroids, within the six weeks preceding enrollment, as well as individuals presenting with neurological or psychiatric comorbidities besides multiple sclerosis. Cognitive baseline screening required a minimum score of 26 on the Montreal Cognitive Assessment, while depressive symptoms were screened out by excluding individuals scoring 20 or higher on the Beck Depression Inventory-II. Of the 76 patients and 67 controls initially enrolled under clinical trial registration DRKS00035204, exclusions for incomplete testing, cognitive cutoff thresholds, or confounding medications yielded a final analytical cohort of 62 patients and 65 controls who did not differ significantly in demographic variables.

The experimental protocol evaluated verbal memory retention through two standardized neuropsychological assessment tools: Rey’s Auditory Verbal Learning Test and the Logical Memory subtest of the Wechsler Memory Scale-IV. In the auditory verbal learning task, participants completed five sequential learning trials consisting of a fifteen-word list, followed by an interference list, after which immediate recall was scored on a scale spanning zero to fifteen points. In the story-learning subtest, participants listened to two structured narratives and recalled as many details as possible, generating an immediate score ranging from zero to fifty points. Both assessments incorporated an intermediate delayed recall session conducted thirty minutes following the original learning phase. To assess accelerated long-term forgetting, researchers obtained an additional delayed recall assessment seven days later via standardized telephone interviews conducted in a quiet setting without distractions. By calculating the ratio of seven-day recall performance relative to thirty-minute delayed recall performance, designated as QRAVLT and QWMS respectively, the team created normalized retention indices that directly captured memory decay across the extended multi-day interval.

The primary cognitive outcomes revealed marked disparities in multi-day memory retention between multiple sclerosis patients and healthy controls despite comparable initial acquisition. On the word-list paradigm, patients achieved a mean retention quotient of 0.64 with a 95 percent confidence interval spanning 0.59 to 0.69, which fell significantly below the control group mean of 0.78 with a confidence interval between 0.73 and 0.82, at p less than 0.001. Similarly, narrative retention on the story-learning subtest yielded a patient quotient of 0.79 with a confidence interval from 0.74 to 0.84, contrasting sharply with the healthy control score of 0.95 with a confidence interval from 0.90 to 1.00, also reaching significance at p less than 0.001. Crucially, immediate recall and thirty-minute delayed recall demonstrated no statistically significant differences between cohorts, and trial-by-trial acquisition curves across initial learning stages were completely identical. Sensitivity analyses using analysis of covariance confirmed that the group effect remained significant after adjusting for thirty-minute recall performance on both tests, with non-significant interaction terms demonstrating that group differences in seven-day retention were independent of short-delay retrieval capacity.

Beyond verbal retention indices, the investigators conducted secondary evaluations to characterize general cognitive processing and patient-reported symptoms across both cohorts. Standardized evaluations of global cognitive status via the Montreal Cognitive Assessment and information processing speed via the Symbol Digit Modalities Test showed no significant differences between patients and healthy controls, confirming that memory degradation occurred without generalized cognitive slowing. In contrast, patient questionnaires revealed pronounced elevations in everyday burdens, with multiple sclerosis participants reporting significantly greater fatigue severity on the Fatigue Impact Scale and poorer sleep quality on the Pittsburgh Sleep Quality Index. Subjective memory difficulties were markedly elevated among patients when measured by the Everyday Memory Questionnaire and structured inventories of daily cognitive complaints known as the FEAG and FEDA. Furthermore, when asked whether they experienced increased forgetfulness in daily life, 22 of 62 patients responded affirmatively compared to 7 of 65 control participants, a contrast mirrored by a significantly higher self-reported forgetfulness rating of 37.26 compared to 29.23 on a visual scale from zero to one hundred.

Spearman correlation analyses revealed meaningful clinical patterns linking long-term memory degradation to patient-reported symptoms and physical impairment within the multiple sclerosis cohort. Greater fatigue severity correlated significantly with lower retention ratios on the word-list assessment, while story recall ratios demonstrated widespread associations with multiple clinical dimensions. Specifically, poorer narrative retention quotients on the Wechsler subtest were significantly associated with more severe fatigue, sleep disturbances, subjective cognitive complaints across the FEAG, FEDA, and Everyday Memory questionnaires, older patient age, and higher physical disability scores on the Expanded Disability Status Scale. In contrast, no corresponding correlations reached statistical significance among healthy controls, indicating that these relationships were specific to pathological processes present in multiple sclerosis. These observations align with earlier hypotheses suggesting that fatigue and subjective cognitive complaints in multiple sclerosis do not primarily disrupt initial encoding or short-term retrieval, but instead selectively undermine the neurobiological stability of memories across extended multi-day intervals.

To determine whether long-term retention indices could serve as a practical indicator of subjective cognitive complaints, the researchers combined the word-list and story quotients into an overall score and performed receiver operating characteristic curve analyses. Evaluating the discriminatory capacity of this combined metric against patients’ self-reported experiences of increased forgetfulness yielded an area under the curve of 0.735, with a 95 percent confidence interval extending from 0.585 to 0.884, indicating moderate diagnostic accuracy. Applying the Youden Index identified an optimal cutoff threshold of 0.71, which produced a sensitivity of 0.727 alongside a specificity of 0.725 for identifying individuals experiencing perceived memory impairment. In the context of cognitive decline, which dementia research models as a continuous spectrum advancing from subclinical changes to subjective cognitive deficits, mild cognitive impairment, and manifest dementia, these metrics suggest that seven-day recall protocols can identify subtle memory vulnerabilities before standard clinical batteries detect measurable dysfunction.

The mechanistic interpretation offered by the authors attributes accelerated long-term forgetting to disruptions in late memory consolidation rather than early encoding mechanisms. In classical memory physiology, the hippocampus orchestrates early acquisition and temporary storage, whereas neocortical networks gradually assume responsibility for sustained information maintenance over prolonged temporal intervals. Functional connectivity studies in temporal lobe epilepsy have demonstrated that accelerated forgetting correlates with reduced resting-state interaction between the anterior hippocampus and the lateral temporal cortex, showing that long-term decay reflects network disconnection rather than isolated hippocampal damage. Because inflammatory demyelination and focal hippocampal damage frequently disrupt subcortical-cortical pathways in multiple sclerosis, the authors suggest that similar neurodegenerative interruptions impair the transfer of acquired information into permanent neocortical storage sites.

Several methodological limitations contextualize the scope and immediate generalizability of the reported results. The experimental battery assessed retention exclusively within the verbal memory domain, leaving unresolved whether visuospatial accelerated forgetting occurs in multiple sclerosis, especially given that prior work utilizing Rey’s complex figure test observed floor-level recall at seven days in both groups. Furthermore, conducting delayed recall assessments over the telephone introduced unblinded examiner conditions and unstandardized home auditory environments, even though instructions directed participants to maintain calm settings. The analytical sample was also heavily weighted toward relapsing-remitting cases, which prevented reliable statistical comparisons across progressive disease phenotypes. Finally, while patients taking centrally active drugs were excluded, 47 of the 62 individuals remained on nonsteroidal disease-modifying therapies whose specific effects on memory consolidation remain insufficiently characterized, highlighting the necessity for longitudinal imaging studies to evaluate how long-term memory metrics track disease progression.

Subject of Research: Accelerated long-term forgetting and subjective memory impairment in patients with multiple sclerosis

Article Title: Accelerated long-term forgetting as an objective marker of subjective memory impairment in multiple sclerosis

Article References: Jansen, C., Stalter, J., Reuter, S., & Witt, K. (2026). Accelerated long-term forgetting as an objective marker of subjective memory impairment in multiple sclerosis. Neurological Research and Practice, 8(1), Article 69. https://doi.org/10.1186/s42466-026-00527-y

Image Credits: AI Generated

DOI: 10.1186/s42466-026-00527-y

Keywords: multiple sclerosis, accelerated long-term forgetting, subjective memory impairment, Rey Auditory Verbal Learning Test, Wechsler Memory Scale, long-term memory consolidation, delayed recall ratio, fatigue, sleep quality, Expanded Disability Status Scale, neuropsychological assessment, verbal memory, hippocampal neocortical networks, relapsing remitting multiple sclerosis, cognitive impairment, receiver operating characteristic analysis

News Source: Ophelia Keating. (November 18, 2026). Seven-Day Recall Tests Reveal Accelerated Long-Term Memory Forgetting in Multiple Sclerosis. Scienmag.

Tags: accelerated long-term forgettingcognitive impairmentdelayed recall ratioExpanded Disability Status Scalefatiguehippocampal neocortical networkslong-term memory consolidationMultiple Sclerosisneuropsychological assessmentreceiver operating characteristic analysisrelapsing-remitting multiple sclerosisRey Auditory Verbal Learning Testsleep qualitysubjective memory impairmentverbal memoryWechsler Memory Scale
Share12Tweet7Share2ShareShareShare1

Related Posts

Multidisciplinary Protocol Aids Mitral Valve Repair in Post-Infarction Shock Case

Multidisciplinary Protocol Aids Mitral Valve Repair in Post-Infarction Shock Case

November 18, 2026
Physical Exercise Linked to Lower Relative Health Disadvantage Among Older Adults

Physical Exercise Linked to Lower Relative Health Disadvantage Among Older Adults

November 18, 2026

Adolescent Brain Connectivity Predicts Depression and Anxiety Trajectories Over 18 Months

November 18, 2026

Medical Education AI Research Rose Sharply After 2021 in Global Analysis

November 18, 2026

POPULAR NEWS

  • Streaming Framework With Hybrid Machine Learning Achieves Sub-Forty-Millisecond Intrusion Detection

    Streaming Framework With Hybrid Machine Learning Achieves Sub-Forty-Millisecond Intrusion Detection

    29 shares
    Share 12 Tweet 7
  • Multidisciplinary Protocol Aids Mitral Valve Repair in Post-Infarction Shock Case

    29 shares
    Share 12 Tweet 7
  • Physical Exercise Linked to Lower Relative Health Disadvantage Among Older Adults

    29 shares
    Share 12 Tweet 7
  • Adolescent Brain Connectivity Predicts Depression and Anxiety Trajectories Over 18 Months

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Genomic Exchange Events Identified as Drivers of Rapeseed Glucosinolate Metabolism

Streaming Framework With Hybrid Machine Learning Achieves Sub-Forty-Millisecond Intrusion Detection

Multidisciplinary Protocol Aids Mitral Valve Repair in Post-Infarction Shock Case

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.